Successful cultivation of a genetically modified pig for a patient with kidney failure – ryan

In a new medical achievement, the United States witnessed the first genetically modified pork cultivation of a 66 -year -old man, after which he was discharged from the hospital in good health, in a move that the Biotechnology company Egenesis considered a “new victory in the world of medicine”, according to UPI.

The operation, conducted in cooperation between Egenesis and Massachusetts General Hospital, is the first of its kind within a multi -patient study aimed at treating people with kidney failure in its final stage.

The patient, Tim Andrews, was suffering from an acute kidney failure that forced him to undergo dialysis sessions for two years, causing him permanent fatigue and heart attack in July 2023 and because of his rare blood type (O), his opportunity to obtain a human college was not exceeding 9%, while his death possibilities during the waiting reached about 49%.

On January 25, a specialized medical team performed a cultivation process during which his sick college was replaced by a genetically modified pork and after less than a week, specifically on the first of February, Andrews was discharged from the hospital and the new college started working efficiently, which stopped his need for dialysis completely.

Commenting on the experiment, Andrews said: “I felt as if I was born again after the operation.

This process falls within three clinical trials conducted by Egenesis, which obtained the approval of the American Food and Drug Administration within the “extended access path” that allows testing innovative medical techniques in critical cases.

For his part, Dr. Leonardo Riela, director of kidney transplantation at the hospital, expressed his hope that this experiment will radically bring about dealing with the crisis of organ deficiency, saying: “We hope this study will contribute to providing long -term solutions to the problem of organ deficiency, and changing the future of kidney patients around the world.”

It is noteworthy that more than 800,000 people in the United States, and millions of others around the world suffer from advanced kidney failure, which makes this scientific progress a new opportunity for many patients looking for an opportunity for life.